These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8895071)

  • 1. Accuracy of the one-sample method for determination of antipyrine clearance in elderly subjects.
    Jorquera F; Almar MM; González-Sastre M; Suarez I; González-Gallego J
    J Pharm Biomed Anal; 1996 Oct; 15(1):7-11. PubMed ID: 8895071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simplified approaches to the determination of antipyrine pharmacokinetic parameters.
    Scavone JM; Greenblatt DJ; Blyden GT; Harmatz JS; Graziano PJ
    Br J Clin Pharmacol; 1988 Jun; 25(6):695-9. PubMed ID: 3203041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of antipyrine kinetics from saliva or plasma: influence of age.
    Jorquera F; Almar MM; Jimeno A; González-Sastre M; González-Gallego J
    J Pharm Biomed Anal; 1995 Aug; 13(9):1141-5. PubMed ID: 8573640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of total body water in hemodialysis patients by a single oral dose of antipyrine.
    Odar-Cederlöf I; Eriksson CG; Albertioni F; Ericsson F; Kjellstrand CM
    ASAIO J; 1996; 42(4):271-4. PubMed ID: 8828783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of age and sex on metabolism and urinary excretion of antipyrine.
    Jorquera F; Almar M; Pozuelo M; Sansegundo D; González-Sastre M; González-Gallego J
    J Gerontol A Biol Sci Med Sci; 1998 Jan; 53(1):M14-9. PubMed ID: 9467428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of aging on antipyrine clearance: predictive factors of metabolizing capacity.
    Jorquera F; Almar MM; Pozuelo M; Sansegundo D; González-Sastre M; González-Gallego J
    J Clin Pharmacol; 1995 Sep; 35(9):895-901. PubMed ID: 8786249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metronidazole clearance: a one-sample method and influencing factors.
    Loft S; Poulsen HE; Sonne J; Døssing M
    Clin Pharmacol Ther; 1988 Apr; 43(4):420-8. PubMed ID: 3356085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic parameters of antipyrine in dog after hepatectomy.
    Galtier M; Briand D; Pinguet F; Gomeni R; Fabre D; Bressolle F
    Biopharm Drug Dispos; 1995 Nov; 16(8):669-84. PubMed ID: 8573686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metronidazole and antipyrine metabolism in the rat: clearance determination from one saliva sample.
    Loft S; Nielsen AJ; Borg BE; Poulsen HE
    Xenobiotica; 1991 Jan; 21(1):33-46. PubMed ID: 2003365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physical exercise and improvement of liver oxidative metabolism in the elderly.
    Mauriz JL; Tabernero B; García-López J; Jorquera F; Villa JG; González-Gallego J
    Eur J Appl Physiol; 2000 Jan; 81(1-2):62-6. PubMed ID: 10552268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simplified determination of antipyrine clearance by liquid chromatography of a microsample of saliva or plasma.
    el-Yazigi A; Raines DA; Ali H; Sieck J; Ernst P; Dossing M
    Pharm Res; 1991 Feb; 8(2):269-72. PubMed ID: 2023880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age and gender effects on chlordiazepoxide kinetics: relation to antipyrine disposition.
    Greenblatt DJ; Divoll MK; Abernethy DR; Ochs HR; Harmatz JS; Shader RI
    Pharmacology; 1989; 38(5):327-34. PubMed ID: 2762375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antipyrine pharmacokinetics and urinary excretion in female horses.
    Dyke TM; Sams RA; Hinchcliff KW
    Am J Vet Res; 1998 Mar; 59(3):280-5. PubMed ID: 9522945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous pharmacokinetics of penicillin G and antipyrine in ostriches (Struthio camelus) and emus (Dromaius novaehollandiae).
    Clarke CR; Kocan AA; Webb AI; Wang Z; Cudd LA
    J Zoo Wildl Med; 2001 Mar; 32(1):74-7. PubMed ID: 12790398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of acute phase response on the plasma clearance of antipyrine, theophylline, phenytoin and nifedipine in rabbits.
    Saitoh T; Kokue E; Shimoda M
    J Vet Pharmacol Ther; 2000 Jun; 23(3):153-8. PubMed ID: 11110102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of antipyrine in calves after intravenous and oral administration.
    Janus K; Muszczynski Z; Suszycka J
    J Vet Pharmacol Ther; 1996 Oct; 19(5):408-10. PubMed ID: 8905578
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of water deprivation on the pharmacokinetics of antipyrine and sulphadimidine following intravenous administration in Nubian goats.
    Elsheikh HA; Osman IA; Abdullah AS
    Vet Res Commun; 1997 Nov; 21(8):587-97. PubMed ID: 9444081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative disposition of pharmacologic markers for cytochrome P-450 mediated metabolism, glomerular filtration rate, and extracellular and total body fluid volume of Greyhound and Beagle dogs.
    KuKanich B; Coetzee JF; Gehring R; Hubin M
    J Vet Pharmacol Ther; 2007 Aug; 30(4):314-9. PubMed ID: 17610404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single- and multiple-dose kinetics of oral lorazepam in humans: the predictability of accumulation.
    Greenblatt DJ; Allen MD; MacLaughlin DS; Huffman DH; Harmatz JS; Shader RI
    J Pharmacokinet Biopharm; 1979 Apr; 7(2):159-79. PubMed ID: 20218012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of the different metabolic pathways of antipyrine in man. Oral versus i.v. administration and the influence of urinary collection time.
    Danhof M; van Zuilen A; Boeijinga JK; Breimer DD
    Eur J Clin Pharmacol; 1982; 21(5):433-41. PubMed ID: 7075648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.